Digitally Enhanced Smoking Cessation for High Risk Smokers
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lung Cancer Screening
- Smoking
- Smoking Behaviors
- Smoking Cessation
- Smoking Tobacco
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 55 years and 77 years
- Gender
- Both males and females
Description
This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. The research study procedures include: screening for eligibility and study interventions including participation in counseling and completion of questionnair...
This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. The research study procedures include: screening for eligibility and study interventions including participation in counseling and completion of questionnaires by e-mail, phone or in-person. This research study involves participating in either the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program or the usual care. Participants will be randomized into one of two groups: ESCAPE: The ESCAPE program provides 8 counseling sessions over the phone, provides nicotine replacement therapy at no cost, and education about lung screening Usual Care: The usual care program will include 1 counseling session, nicotine replacement therapy at no cost referral and enrollment in quitworks Participants will be in this research study for up to 6-months. It is expected that about 250 people will take part in this research study.
Tracking Information
- NCT #
- NCT04691297
- Collaborators
- American Association for Cancer Research
- Investigators
- Principal Investigator: Mary E. Cooley, PhD Dana-Farber Cancer Institute